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Healthy Vision Month — May 2019
May is Healthy Vision Month, an annual observance 
dedicated to making vision and eye health a national 
priority. During this month, CDC’s Vision Health 
Initiative (VHI) in the Division of Diabetes Translation 
joins with the National Eye Institute’s National Eye Health 
Education Program to educate the public about preventing 
vision loss and promoting eye health. Almost 3.22 million 
U.S. persons are affected by vision impairment, which can 
be associated with social isolation, disability, and decreased 
quality of life (https://www.cdc.gov/visionhealth/risk/
burden.htm).
In this issue of MMWR, VHI staff members report find-
ings from their study examining the association of vision 
impairment and functional limitations related to subjec-
tive cognitive decline (SCD), defined as the experience of 
worsening or more frequent confusion or memory loss (1). 
Analysis of data from the Behavioral Risk Factor Surveillance 
System survey for the years 2015–2017 indicated that 
persons with vision impairment were 3.5 times more likely 
to report functional limitations related to SCD than were 
those with no vision impairment.
With the number of U.S. adults with vision impairment 
projected to double in the next 30 years (2), understanding 
the impact of comorbid vision and SCD on functioning is 
just one of many important public health concerns related 
to vision loss. For information on topics related to vision and 
eye health, including common eye disorders, prevention, 
and related state and community programs, please visit the 
VHI web page (https://www.cdc.gov/visionhealth).
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Vision Impairment and Subjective 
Cognitive Decline–Related 
Functional Limitations — United 
States, 2015–2017
Sharon Saydah, PhD1; Robert B. Gerzoff, MS1; Christopher A. Taylor, PhD2; 
Joshua R. Ehrlich, MD3; Jinan Saaddine, MD, PhD1
Vision impairment affects approximately 3.22 million 
persons in the United States and is associated with social iso-
lation, disability, and decreased quality of life (1). Cognitive 
decline is more common in adults with vision impairment 
(2,3). Subjective cognitive decline (SCD), which is the self-
reported experience of worsening or more frequent confusion 
or memory loss within the past 12 months, affects 11.2% of 
adults aged ≥45 years in the United States (4). One conse-
quence of SCD is the occurrence of functional limitations, 
especially those related to usual daily activities; however, it is 
not known whether persons with vision impairment are more 
likely to have functional limitations related to SCD (4). This 
report describes the association of vision impairment and 
SCD-related functional limitations using Behavioral Risk 
Factor Surveillance System (BRFSS) surveys for the years 
2015–2017. Adjusting for age group, sex, race/ethnicity, 
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education level, health insurance, and smoking status, 18% 
of adults aged ≥45 years who reported vision impairment also 
reported SCD-related functional limitations, compared with 
only 4% of those without vision impairment. Preventing, 
reducing, and correcting vision impairments might lead to a 
decrease in SCD-related functional limitations among adults 
in the United States.
This analysis used data from the BRFSS, an annual state-
based, cross-sectional telephone survey of noninstitutionalized 
adults aged ≥18 years, combining data from 2015, 2016, 
and 2017.* During those 3 years, 208,601 respondents aged 
≥45 years in 49 states (all except Pennsylvania), Puerto Rico, 
and the District of Columbia (DC) completed the optional 
cognitive decline module.†,§,¶ For states that administered the 
module in multiple years, only the most recent year’s data were 
included. For the BRFSS surveys in 2015, 2016, and 2017, 
the combined landline and cellular telephone response rates 
among states, Puerto Rico, and DC ranged from 30.6% to 
64.1% (median = 45.7%).
Among all respondents aged ≥45 years, those classified 
as having SCD responded affirmatively to the question 
“During the past 12 months, have you experienced confu-
sion or memory loss that is happening more often or is 
* https://www.cdc.gov/brfss.
† https://www.cdc.gov/brfss/annual_data/2015/pdf/2015-sdqr.pdf.
§ https://www.cdc.gov/brfss/annual_data/2016/pdf/2016-sdqr.pdf.
¶ https://www.cdc.gov/brfss/annual_data/annual_2017.html.
getting worse?” Respondents with SCD were then asked 
two follow-up questions: 1) “During the past 12 months, 
as a result of confusion or memory loss, how often have you 
given up day-to-day household activities or chores you used 
to do, such as cooking, cleaning, taking medications, driv-
ing, or paying bills?” and 2) “During the past 12 months, 
how often has confusion or memory loss interfered with 
your ability to work, volunteer, or engage in social activities 
outside the home?” Responses of “always,” “usually,” and 
“sometimes” were classified as positive responses, and responses 
of “rarely” and “never” were classified as negative responses 
(4). Functional limitations caused by SCD were defined as 
a positive response to either of the two follow-up questions. 
Vision impairment was defined as a yes response to the question 
“Are you blind or do you have serious difficulty seeing, even 
when wearing glasses?” Descriptive analyses examined popu-
lation characteristics by vision impairment and SCD-related 
functional limitations status. Covariates included age group 
(45–64 years, 65–74 years, or ≥75 years); sex (male or female); 
race/ethnicity (non-Hispanic white, non-Hispanic black, 
non-Hispanic multiracial, Hispanic, or non-Hispanic other); 
education level (less than high school, high school graduate 
or some college, or college graduate); smoking status (never, 
former, or current); and having health insurance (yes or no). 
Multivariate logistic regression models were used to calculate 
predicted marginal proportions and examine the relationship 
between vision impairment and SCD-related functional limi-
tations, adjusting for age, sex, race/ethnicity, education level, 
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and smoking status. All estimates used the BRFSS-provided 
sampling weights to account for the complex survey design 
and nonresponse. Analysis was completed using SUDAAN 
(version 11.0.3; RTI International).
The overall prevalence of vision impairment among respon-
dents was 6.2% (95% confidence interval [CI] = 6.0%–6.3%), 
and the overall prevalence of SCD with functional limitations 
was 5.5% (95% CI = 5.3%–5.7%). The prevalence of vision 
impairment without functional limitations related to SCD 
increased with age from 4.4% (95% CI = 4.2%–4.7%) among 
those aged 45–64 years to 7.2% (95% CI  =  6.7%–7.6%) 
for those aged ≥75 years (Table). Among adults reporting 
SCD-related functional limitations without vision impair-
ment, the proportion in each of the three age groups was 
similar (range = 2.8 [65–74 years] to 4.4 [45–64 years]), as 
was the age distribution among those with vision impair-
ment (range = 0.9% [age 65–74 years] to 1.8 [45–64 years]). 
Similarly, no significant differences in report of SCD-related 
functional limitations among those with and without vision 
impairment were seen when stratified by race/ethnicity.  Vision 
impairment without SCD related limitations was highest 
among Hispanics (10.4%, 95% CI = 9.3–11.6) and lowest 
among non-Hispanic whites (3.6%, 95% CI = 3.5%–3.8%). 
However, prevalences of vision impairment and SCD-related 
functional limitations were higher among adults with less than 
a high school diploma (4.1%, 95% CI = 3.6%–4.6%), who 
were current smokers (3.6%, 95% = 3.2%–4.0%), and who did 
not have health insurance (3.0%, 95% CI = 2.5%–3.7%) than 
among college graduates (0.4%, 95% CI = 0.3%–0.4%), those 
who had never smoked (0.9%, 95% CI = 0.8%–1.1%), and 
those who had health insurance (1.4%, 95% CI =1.3%–1.5%).
After adjusting for demographics, smoking status, and vision 
impairment, the prevalence of functional limitations related to 
SCD was highest among persons aged 45–64 years (6%) and 
lowest among those aged 65–74 years (4%; p<0.001) (Figure). 
In addition, non-Hispanic whites and Hispanics reported 
the lowest prevalences (5%), and non-Hispanic persons of 
other races reported the highest prevalence (8%) (p<0.001). 
The prevalence of SCD-related functional limitations among 
persons having less than a high school education (9%) was 
three times that of those reporting being a college graduate 
(3%) (p<0.001). Being a current smoker was associated with 
a higher prevalence of SCD-related functional limitations 
(9%), compared with being a former smoker (5%) or a person 
TABLE. Percentage of adults aged ≥45 years who reported vision impairment with and without subjective cognitive decline (SCD)–related 
functional limitations (FL), by selected characteristics — Behavioral Risk Factor Surveillance System, 49 states, Puerto Rico, and District of 
Columbia, 2015–2017
Characteristic
Vision and SCD-related FL status, % (95% CI)
Overall
No vision impairment, 
no SCD-related FL
No vision impairment, 
with SCD-related FL
Vision impairment, 
no SCD-related FL
Vision impairment, 
with SCD-related FL
Overall 100 89.7 (89.4–89.9) 3.9 (3.8–4.1) 4.9 (4.7– 5.1) 1.5 (1.4–1.6)
Age group (yrs)
45–64 63.1 (62.8–63.3) 89.4 (89.0–89.8) 4.4 (4.1–4.6) 4.4 (4.2–4.7) 1.8 (1.6–2.0)
65–74 21.6 (21.4–21.8) 91.8 (91.4–92.2) 2.8 (2.5–3.0) 4.6 (4.3–4.9) 0.9 (0.8–1.0)
≥75 15.3 (15.2–15.5) 87.8 (87.2–88.4) 3.9 (3.6–4.3) 7.2 (6.7–7.6) 1.1 (0.9–1.3)
Sex
Male 47.0 (46.8–47.3) 90.1 (89.7–90.5) 3.9 (3.7–4.1) 4.7 (4.4–4.9) 1.3 (1.2–1.5)
Female 53.0 (52.7–53.2) 89.3 (88.9–89.7) 4.0 (3.8–4.2) 5.1 (4.8–5.4) 1.6 (1.5–1.8)
Race/Ethnicity*
White, non-Hispanic 68.4 (68.1–68.8) 91.7 (91.4–91.9) 3.6 (3.5–3.8) 3.6 (3.5–3.8) 1.0 (0.9–1.2)
Black, non-Hispanic 10.1 (9.9–10.3) 85.4 (84.3–86.3) 4.9 (4.3–5.4) 7.0 (6.2–7.8) 2.8 (2.4–3.3)
Multiracial, non-Hispanic 1.2 (1.2–1.3) 84.6 (82.0–86.9) 5.9 (4.6–7.6) 7.6 (5.9–9.7) 1.9 (1.3–2.8)
Hispanic 13.9 (13.6–14.2) 82.2 (80.8–83.6) 4.5 (3.9–5.2) 10.4 (9.3–11.6) 2.9 (2.3–3.5)
Other, non-Hispanic 6.4 (6.1–6.6) 88.8 (87.1–90.3) 4.4 (3.6–5.4) 5.0 (4.0–6.2) 1.8 (1.2–2.7)
Education level
Less than high school graduate 14.7 (14.4–14.9) 76.5 (75.3–77.7) 7.3 (6.7–8.0) 12.1 (11.1–13.1) 4.1 (3.6–4.6)
High school graduate/Some college 57.0 (56.7–57.3) 89.7 (89.4–90.1) 4.3 (4.0–4.5) 4.5 (4.3–4.8) 1.5 (1.3–1.6)
College graduate 28.3 (28.1–28.6) 95.7 (95.5–95.9) 1.7 (1.6–1.9) 2.2 (2.1–2.4) 0.4 (0.3–0.4)
Smoking status
Never smoked 54.0 (53.7–54.3) 91.8 (91.4–92.1) 3.0 (2.8–3.2) 4.3 (4.0–4.5) 0.9 (0.8–1.1)
Former smoker 31.9 (31.7–32.2) 90.0 (89.5–90.4) 3.7 (3.5–4.0) 4.8 (4.5–5.1) 1.5 (1.3–1.8)
Current smoker 14.1 (13.9–14.3) 81.2 (80.3–82.1) 7.8 (7.2–8.4) 7.4 (6.7–8.1) 3.6 (3.2–4.0)
Health insurance status
Health insurance 93.0 (92.8–93.1) 90.1 (89.9–90.4) 3.8 (3.7–4.0) 4.6 (4.5–4.8) 1.4 (1.3–1.5)
No health insurance 7.0 (6.9–7.2) 83.2 (81.6–84.7) 5.3 (4.5–6.3) 8.5 (7.3–9.8) 3.0 (2.5–3.7)
Abbreviation: CI = confidence interval.
* Whites, blacks, multiracial, and other races/ethnicities were non-Hispanic; Hispanic persons could be of any race.
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FIGURE. Adjusted percentage* of subjective cognitive decline (SCD)–related functional limitations among adults aged ≥45 years, by demographic 
characteristics, smoking status, and vision impairment — Behavioral Risk Factor Surveillance System, 49 states,† Puerto Rico, and the District 
of Columbia, 2015–2017
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Abbreviation: HS = high school.
* Adjusted prevalence based on predicted marginal from logistic regression models adjusting for age, sex, race/ethnicity, smoking status, health insurance status, 
and vision impairment.
† Excluding Pennsylvania. 
who had never smoked (4%) (p<0.001). After adjusting for 
demographics and smoking status, the highest prevalence of 
SCD-related functional limitations (18%) was among adults 
with vision impairment; prevalence among those with no 
reported vision impairment was 4% (p<0.001).
Discussion
Functional limitations have been reported by 50% of adults 
aged ≥45 years with SCD (4), and vision impairment has been 
reported by 6% (5). Previous studies have determined that 
vision impairment and cognitive decline might co-occur (2) 
and might be causally related (3). Recent studies have pointed 
to changes in the retina as a potential biomarker for dementia 
(6), highlighting the link between vision impairment and 
cognitive decline. However, the association of vision impair-
ment with SCD-related functional limitations has not been 
well characterized. This report found that among adults aged 
≥45 years, SCD-related functional limitations were three and 
one half times higher among adults with vision impairment 
than among those with no vision impairment. The number of 
adults in the United States with vision impairment is projected 
to double in the next 30 years (5); therefore, understanding 
the impact of co-occurring vision impairment and SCD on 
functional abilities is an important public health concern.
Vision impairment might lead to decreased quality of life, 
functional limitations, and an increased risk of mortality (7,8). 
Vision impairment might prevent persons from performing 
instrumental activities of daily living. However, a previous 
study found that the relationship between vision impairment 
and cognitive decline might be modified by a tailored vision 
rehabilitation program (9). Further work can help to determine 
whether vision rehabilitation is also an effective strategy to 
improve functional limitations associated with SCD.
Vision impairment can be caused by treatable forms of 
vision loss such as cataracts and refractive errors, along with 
age-related macular degeneration, diabetic retinopathy, and 
glaucoma. Measures to prevent vision impairment and vision 
loss include receiving eye care and a comprehensive eye 
exam. Additional ways to protect eyes and prevent vision loss 
include knowing family history of eye health, eating healthy, 
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maintaining healthy weight, wearing protective eyewear, quit-
ting or never starting smoking, washing hands before removing 
contact lens, and practicing workplace eye safety.
The findings in this report are subject to at least three limi-
tations. First, these results are based on self-reported vision 
difficulty and SCD-related functional limitations. Objective 
measures of cognitive and visual functioning were not admin-
istered as part of BRFSS (4). Second, response bias might have 
affected the response to questions on vision impairment, SCD, 
and functional limitations. For example, older persons might be 
less likely to report SCD-related functional limitations if they 
consider them to be part of the aging process, thus reducing 
the reported prevalence of these limitations in this population. 
Finally, BRFSS is only administered to noninstitutionalized 
adults, thereby excluding those living in long-term care facili-
ties where nearly one third of residents might have vision and 
cognitive impairments (10). These limitations might have 
biased these results toward the null hypothesis and might limit 
their generalizability across all populations. The strength of 
this analysis is that it includes nearly all states, Puerto Rico, 
and DC, representing 253 million U.S. adults.
Vision impairment is an important, growing public health 
concern in the United States (5). Adults with vision impairment 
might have higher levels of difficulties with activities of daily 
living (e.g., eating and bathing) and instrumental activities of 
daily living (e.g., managing finances and using a telephone) 
(10). Having vision impairment might increase the likelihood 
that persons with SCD report related functional limitations. 
Addressing vision impairment through prevention or corrective 
treatment might reduce functional SCD-associated limitations 
in the adult population.
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Summary
What is already known about this topic?
Vision impairment often co-occurs with cognitive decline, 
which can be associated with functional limitations. The 
association between vision impairment and functional 
limitations related to subjective (self-reported) cognitive decline 
(SCD) has not been well characterized.
What is added by this report?
Analysis of 2015–2017 Behavioral Risk Factor Surveillance 
System data determined that, after adjusting for age and other 
demographic and smoking characteristics, 18% of adults who 
reported vision impairment also reported SCD-related func-
tional limitations, compared with only 4% of those without 
vision impairment.
What are the implications for public health practice?
Prevention or correction of vision impairment might be 
important in in reducing functional limitations related to 
cognitive decline in adults aged ≥45 years.
